Health Outcomes, Discrimination, and Stigma Among Sexual and Gender Minority People With Inflammatory Bowel Disease Get access

• Abstract
• Lay summary

Why Symptoms Linger in Quiescent Crohn’s Disease: Investigating the Impact of Sulfidogenic Microbes and Sulfur Metabolic Pathways Get access

• Abstract
• Lay summary
• Supplementary data

Durable Immune Response and Long-term Efficacy of COVID-19 Vaccination in Children With Inflammatory Bowel Disease Get access

• Abstract
• Lay summary

Extended Induction and Prognostic Indicators of Response in Patients Treated with Mirikizumab with Moderately to Severely Active Ulcerative Colitis in the LUCENT Trials

• Abstracts
• Lay summary
• Supplementary data

Use of Upadacitinib in 16 Tofacitinib-refractory Ulcerative Colitis Patients: A Single-center Case 2Series

Are Depression and Anxiety Underdiagnosed in Socially Vulnerable Patients With Inflammatory Bowel Disease?

• Abstract
• Lay summary
• Supplementary data

Profiles of Web-based Portal Users with Inflammatory Bowel Disease

• Abstract
• Lay summary
• Supplementary data

Induction and Maintenance Treatment With Upadacitinib Improves Health-Related Quality of Life in Patients With Moderately to Severely Active Ulcerative Colitis: Phase 3 Study Results

• Abstract
• Lay summary
• Supplementary data

Low Rates of Breakthrough COVID-19 Infection After SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease

The Relationship Between Opioid Use and Healthcare Utilization in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

• Abstract
• Lay summary
• Supplementary data

Inflammatory Bowel Disease Risk Variants Are Associated with an Increased Risk of Skin Cancer

• Abstract
• Supplementary data

Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID

• Abstract
• Lay summary

Efficacy of Ustekinumab in Crohn’s Disease With and Without Concurrent Autoimmune Skin Disease

• Abstract

Effect of ABT-263 on Intestinal Fibrosis in Human Myofibroblasts, Human Intestinal Organoids, and the Mouse Salmonella typhimurium Model

• Abstract
• Lay summary
• Supplementary data

AXL Is a Potential Target for the Treatment of Intestinal Fibrosis

• Abstract
• Supplementary data

Variations in Health Care Utilization Patterns Among Inflammatory Bowel Disease Patients at Risk for High Medical Service Utilization Enrolled in High Deductible Health Plans

• Abstract
• Supplementary data

Trends of 5-Aminosalicylate Medication Use in Patients With Crohn Disease

• Abstract

Endoscopic and Histological Assessment, Correlation, and Relapse in Clinically Quiescent Ulcerative Colitis (MARQUEE) Get access

• Abstract
• Supplementary data

Temporal Gut Microbial Changes Predict Recurrent Clostridiodes Difficile Infection in Patients With and Without Ulcerative Colitis Get access

• Abstract
• Supplementary data

Assessing Small Bowel Stricturing and Morphology in Crohn’s Disease Using Semi-automated Image Analysis

• Abstract